Category: Accuray Inc.
Radiotherapy devices maker Accuray settles a patent infringement claim from Radiation Stabilization Solutions for $150,000.
A drawing from Radiation Stabilization Solutions' patent.
Radiotherapy devices maker Accuray reports a 18% dive in 1st-quarter sales as the company comes down from previous spikes associated with a merger.
Accuray (NSDQ:ARAY) lost a little love on Wall Street after the company reported a sizable dive in sales for its 1st quarter 2013.
The FDA grants 510(k) clearance to Accuray's CyberKnife M6 radiosurgery device for treating cancerous tumors.
Accuray (NSDQ:ARAY) won 510(k) clearance from the FDA for the latest iteration of its CyberKnife radiosurgery device.
Chief commercial officer Kelly Londy told MassDevice.com that the Sunnyvale, Calif.-based medical device company is launching the product immediately.
Euan Thomson abruptly resigns from Sunnyvale, Calif.-based medical device maker Accuray, will be replaced by former Mentor Corp., Immucor CEO.
Medical device company Accuray (NSDQ:ARAY) said CEO Euan Thomson has left the company and will be replaced by Joshua Levine, the former CEO of Mentor Corp. and Immucor.
Medical device maker Accuray reports that its losses jumped 170% during fiscal 2012, cautioning that Q1 results will be dramatically lower as it ramps up for a new product launch this fall.
Medical device company Accuray (NSDQ:ARAY) said it's completed a "year of transition" as it looks to the release of 2 new products in October, which it says will help "change the dynamic" of the radiosurgery market.